{"id":425024,"date":"2024-10-20T06:54:37","date_gmt":"2024-10-20T06:54:37","guid":{"rendered":"https:\/\/pdfstandards.shop\/product\/uncategorized\/bs-en-iso-10993-102023\/"},"modified":"2024-10-26T13:00:55","modified_gmt":"2024-10-26T13:00:55","slug":"bs-en-iso-10993-102023","status":"publish","type":"product","link":"https:\/\/pdfstandards.shop\/product\/publishers\/bsi\/bs-en-iso-10993-102023\/","title":{"rendered":"BS EN ISO 10993-10:2023"},"content":{"rendered":"
This document specifies the procedure for the assessment of medical devices and their constituent materials with regard to their potential to induce skin sensitization. This document includes: \u2014 details of in vivo skin sensitization test procedures; \u2014 key factors for the interpretation of the results. NOTE Instructions for the preparation of materials specifically in relation to the above tests are given in Annex A.<\/p>\n
PDF Pages<\/th>\n | PDF Title<\/th>\n<\/tr>\n | ||||||
---|---|---|---|---|---|---|---|
2<\/td>\n | undefined <\/td>\n<\/tr>\n | ||||||
7<\/td>\n | Annex ZA (informative)Relationship between this European standard and the General Safety and Performance requirements of Regulation (EU) 2017\/745 aimed to be covered <\/td>\n<\/tr>\n | ||||||
10<\/td>\n | Blank Page <\/td>\n<\/tr>\n | ||||||
13<\/td>\n | Foreword <\/td>\n<\/tr>\n | ||||||
14<\/td>\n | Introduction <\/td>\n<\/tr>\n | ||||||
15<\/td>\n | 1 Scope 2 Normative references 3 Terms and definitions <\/td>\n<\/tr>\n | ||||||
17<\/td>\n | 4 General principles \u2014 Step-wise approach <\/td>\n<\/tr>\n | ||||||
18<\/td>\n | 5 Pretest considerations 5.1 General 5.2 Types of material 5.2.1 Initial considerations 5.2.2 Ceramics, metals and alloys 5.2.3 Polymers 5.2.4 Biologically derived materials 5.3 Information on chemical composition 5.3.1 General <\/td>\n<\/tr>\n | ||||||
19<\/td>\n | 5.3.2 Existing data sources 6 Skin sensitization tests 6.1 Choice of test methods <\/td>\n<\/tr>\n | ||||||
20<\/td>\n | 6.2 Murine local lymph node assay 6.2.1 Principle 6.2.2 Test sample preparation 6.2.3 Animals and husbandry <\/td>\n<\/tr>\n | ||||||
21<\/td>\n | 6.2.4 Test procedure <\/td>\n<\/tr>\n | ||||||
22<\/td>\n | 6.2.5 Treatment groups 6.2.6 Determination of cellular proliferation and tissue preparation <\/td>\n<\/tr>\n | ||||||
23<\/td>\n | 6.2.7 Results and interpretation 6.2.8 Test report 6.3 Guinea pig assays for the detection of skin sensitization 6.3.1 Principle <\/td>\n<\/tr>\n | ||||||
24<\/td>\n | 6.3.2 Choice of test sample concentrations 6.3.3 Induction 6.3.4 Challenge 6.4 Important factors affecting the outcome of the test <\/td>\n<\/tr>\n | ||||||
25<\/td>\n | 6.5 Guinea pig maximization test 6.5.1 Principle 6.5.2 Test sample preparation 6.5.3 Animals and husbandry <\/td>\n<\/tr>\n | ||||||
26<\/td>\n | 6.5.4 Test procedure <\/td>\n<\/tr>\n | ||||||
28<\/td>\n | 6.5.5 Observation of animals 6.5.6 \u200bEvaluation of results <\/td>\n<\/tr>\n | ||||||
29<\/td>\n | 6.5.7 Test report 6.6 Closed-patch test (Buehler test) 6.6.1 Principle 6.6.2 Test sample preparation 6.6.3 Animals and husbandry <\/td>\n<\/tr>\n | ||||||
30<\/td>\n | 6.6.4 Test procedure <\/td>\n<\/tr>\n | ||||||
31<\/td>\n | 6.6.5 Observation of animals 6.6.6 \u200bEvaluation of results 6.6.7 Test report <\/td>\n<\/tr>\n | ||||||
32<\/td>\n | 7 Key factors in interpretation of test results <\/td>\n<\/tr>\n | ||||||
33<\/td>\n | Annex A (normative) Preparation of materials for skin sensitization testing <\/td>\n<\/tr>\n | ||||||
35<\/td>\n | Annex B (informative) Method for the preparation of extracts from polymeric test materials <\/td>\n<\/tr>\n | ||||||
38<\/td>\n | Annex C (informative) Non-animal methods for skin sensitization <\/td>\n<\/tr>\n | ||||||
51<\/td>\n | Annex D (informative) Background information on sensitization tests for skin sensitization <\/td>\n<\/tr>\n | ||||||
54<\/td>\n | Bibliography <\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":" Biological evaluation of medical devices – Tests for skin sensitization<\/b><\/p>\n |